RTI Biologics Announces Launch of BioReady DBM Putty
10/26/2012 7:23:51 AM
ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching a new biologic implant for use in sports medicine, orthopedic and spine surgeries. BioReady™ DBM Putty and Putty with Chips is a ready-to-use, 100 percent allograft DBM solution. BioReady DBM Putty is an extension of RTI Biologics’ DBM portfolio which includes BioSet™ DBM Paste and BioAdapt™ Foam.